🔗 Share this article Texas Attorney General Files Lawsuit Against Acetaminophen Producers Concerning Autism Claims The Texas Attorney General, who supports former President Trump seeking election to the United States Senate, alleged pharmaceutical manufacturers of hiding potential dangers of Tylenol Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the companies concealed safety concerns that the pain reliever created to pediatric neurological development. The court filing arrives thirty days after Donald Trump publicized an unverified association between taking acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children. Paxton is filing suit against the pharmaceutical giant, which once produced the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which presently makes it. In a statement, he said they "misled consumers by gaining financially from suffering and pushing pills without regard for the dangers." The manufacturer states there is no credible evidence connecting Tylenol to autism. "These corporations deceived for years, intentionally threatening countless individuals to boost earnings," Paxton, from the Republican party, declared. The manufacturer stated officially that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the welfare of American women and children." On its website, the company also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that shows a established connection between taking paracetamol and autism spectrum disorder." Groups acting on behalf of medical professionals and healthcare providers agree. The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in Tylenol - is a restricted selection for women during pregnancy to manage pain and fever, which can present serious health risks if ignored. "In over twenty years of investigation on the use of paracetamol in pregnancy, not a single reputable study has definitively established that the consumption of acetaminophen in any period of pregnancy leads to neurodevelopmental disorders in young ones," the organization commented. The court filing references current declarations from the previous government in arguing the medication is potentially dangerous. In recent weeks, the former president caused concern from public health officials when he told expectant mothers to "fight like hell" not to use acetaminophen when unwell. The FDA then published an announcement that doctors should consider limiting the usage of Tylenol, while also mentioning that "a proven link" between the medication and autism in young ones has remains unverified. The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in April to undertake "a massive testing and research effort" that would establish the source of autism spectrum disorder in a limited time. But specialists warned that finding a single cause of autism - considered by experts to be the consequence of a complicated interplay of genetic and environmental factors - would be difficult. Autism spectrum disorder is a category of enduring cognitive variation and impairment that affects how people encounter and interact with the world, and is identified using doctors' observations. In his lawsuit, the attorney general - a Trump ally who is seeking federal office - claims Kenvue and J&J "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism. This legal action aims to force the corporations "destroy any marketing or advertising" that claims acetaminophen is safe for pregnant women. The Texas lawsuit echoes the grievances of a assembly of parents of children with autism and ADHD who took legal action against the manufacturers of acetaminophen in 2022. A federal judge rejected the legal action, declaring studies from the family's specialists was inconclusive.